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more, the occurrence of slow-ﬂow, no-reﬂow, vessel dissection and branch vessel jail
are recorded.
Results: Baseline demographics and clinical characteristics, including age, sex,
smoking, ect, were similar between the two groups. There were not signiﬁcantly
different in baseline lesion characteristics. The maximum calcium arc and
calcium length ratio were (215.921.8) and (0.720.06) in RA group matched
with (226.521.6) and (0.780.05) in RC group, P>0.05. Before stent im-
plantation, the minimum lumen CSA was (2.520.07) mm2 in RA group and
(2.460.09) mm2 in RC group, without difference.The size of RA bur was
(1.44+0.02) mm and (1.46+0.01) mm in two groups, P>0.05. The cutting
balloon diameter used in RC group was (2.56+0.04) mm. The stent size were
(2.93+0.08) mm in RA group and (3.09+0.08) mm in RC group, P>0.05. After
RA and RA combined cutting balloon, there were 12 (35.3%) cases in RA
group and 26 (56.5%) cases in RC group could see the gaps, P¼0.189.
Although there was no statistical deference between the two groups, there was a
trend in RC group that more cases appear gaps after the adequate plaque
modiﬁcation.After stent implantation, the minimum stent area after stent im-
plantation and acute lumen gain of RC group were signiﬁcantly greater than
that of the RA group ((6.120.37) mm2 vs (5.420.24) mm2, P¼0.012;
(3.660.34) mm2 vs (2.900.24) mm2, P¼0.016). There were no statistical
differences in the occurrence of slow ﬂow, no-reﬂow, branch vessel jail and
vessel dissection between the two groups.
Conclusions: Rotational atherectomy combined with cutting balloon for treatment of
severely calciﬁed coronary lesions could signiﬁcantly increase the stent area, acute
lumen gain compared with rotational atherectomy alone, without increasing the PCI-
related complications.GW25-e1118
The Inﬂuence of Calcium Parameters for Immediate PCI Results:
An Intravascular Ultrasound Analysis
Tang Zhe, Bai Jing, Wang Yu
Chinese PLA General Hospital
Objectives: This IVUS study was designed to evaluate how calciﬁed parameters
(including calcium arc, calcium length ratio and calcium index) inﬂuence the results of
PCI.
Methods: From January 2012 to October 2012, 105 consecutive coronary artery
disease patients who underwent primary angioplasty with IVUS were analyzed in
our center. There were 34 no-calciﬁed lesions (no calcium of all lesion seg-
ments), 32 light-calciﬁed lesions (calcium length ratio<0.5 or calcium arc<180),
and 40 severe-calciﬁed lesions (calcium length ratio0.5 and calcium
arc180).IVUS was performed before percutaneous coronary intervention (PCI)
to measured lumen cross-sectional area (CSA), external elastic membrane (EEM),
Plaque and media CSA ¼ EEM CSA-lumen CSA. Lumen CSA of every 1 mm
of culprit lesion segment was measured and average lumen CSA was calculated.
For calcium, we measured maximum calcium arc, calcium length, and calcium
ratio (calcium length/lesion length). After stent implantation, IVUS was
rechecked to measure minimum stent CSA, minimum and maximum stent
diameter, and the reference lumen CSA. Stent symmetry ¼ minimum stent
diameter/maximum stent diameter. Stent expansion ¼ minimum stent CSA/
reference lumen CSA. Stent malapposition was deﬁned as insufﬁciently close
contact between some struts and the underlying wall. Stent asymmetry was
deﬁned as stent symmetry of at least one section<0.7. Stent underexpansion was
deﬁned as stent expansion rate <0.8.
Results: Severely calciﬁed lesions had smaller minimum lumen CSA, mean lumen
area, and minimum stent lumen CSA after PCI. And in severely calciﬁed lesions,
there was a higher occurrence of vessel dissection, vessel jail, stent malapposition,
stent asymmetry, and stent under-expansion. In all calciﬁed lesions, calcium arc has
a stronger inﬂuence for minimum lumen area (R2¼0.174, P¼0.000), minimum
stent area (R2¼0.256, P¼0.000), acute lumen gain (R2¼0.168, P¼0.000), and stent
expansion (R2¼0.103, P¼0.003) than calcium length ratio (min lumen area:
R2¼0.005, P¼0.445; min stent area: R2¼0.085, P¼0.007; acute lumen gain:
R2¼0.074, P¼0.012; stent expansion: R2¼0.007, P¼0.222) and calcium index (min
lumen area: R2¼0.108, P¼0.002; min stent area: R2¼0.237, P¼0.000; acute lumen
gain: R2¼0.167, P¼0.000; stent expansion: R2¼0.086, P¼0.007). Calcium length
ratio has a stronger inﬂuence for vessel dissection (OR¼7.528, 95%CI 1.395-
40.643, P¼0.019) than calcium arc (OR¼1.005, 95%CI 1.001-1.010, P¼0.026) and
calcium index (OR¼5.647, 95%CI 1.195-26.678, P¼0.029). Calcium index
(R2¼0.261, P¼0.000) has stronger inﬂuence for mean lumen area and incomplete
stent apposition (OR¼19.658, 95%CI 3.233-119.509, P¼0.001) than calcium arc
(mean lumen area R2¼0.158, P¼0.000; incomplete stent apposition OR¼1.011,
95%CI 1.004-1.018, P¼0.001) and calcium length ratio (mean lumen area
R2¼0.236, P¼0.000; incomplete stent apposition OR¼12.945, 95%CI 1.766-
94.913, P¼0.012). Vessel loss seemed to have no liner relationship with calcium
parameters.
Conclusions: For calciﬁed lesions, we should consider both calcium arc and length.
The minimum lumen area, minimum stent area, acute lumen gain, and stent expansion
are mainly affected by calcium arc. Stent symmetry and the occurrence of vessel
dissection are mainly affected by calcium length ratio. Mean lumen area and stent
malapposition are mainly affected by calcium index.JACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/CGW25-e2152
Ischemic Postconditioning versus Remote Ischemic Conditioning in Patients
Treated with Primary Percutaneous Coronary Intervention: A Bayesian
Network Meta-analysis
Wang Lei, Wang Jingping, Han Huiyuan, Xu Huiyu, Zhang Haozhou, Li Bao
Shanxi Cardiovascular Hospital, Taiyuan, Shanxi, China
Objectives: The aim of present analysis was to compare ischemic postconditioning
(IPC) with remote ischemic conditioning (RIPC) in primary percutaneous coronary
intervention (pPCI), a network meta-analysis was performed using a Bayesian
approach.
Methods: Published randomized controlled trials included either IPC or RIPC in
patients with ST-elevation acute myocardial infarction (STEMI) during pPCI were
identiﬁed though the PubMed, EMBASE, and Cochrane central Register of Controlled
Trials database, and the ClinicalTrials.gov database up to December 2013. Outcomes
of interest were enzymatic infarct size, infarct size assessed by cardiac magnetic
resonance (CMR), complete ST-segment resolution (cSTR) and cardiac events during
follow-up. A Bayesian network meta-analysis was performed using WinBUGS 1.43
and R 3.02.
Results: Sixteen studies including results of 1773 IPC and RIPC patients were
identiﬁed. Pooled results showed no signiﬁcant decrease in enzymatic infarct size
among patients treated with IPC compared to RIPC (standardized mean difference
[SMD], -0.17; 95% Conﬁdence Interval [CI], -6.62 to 6.57). Compared with IPC,
RIPC tended to reduce infarct size evaluated by CMR. (Mean difference [MD],
2.77%; 95%CI,-6.40% to 12.17%).There was a trend toward more cSTR in IPC pa-
tients than in RIPC subjects (odds ratio [OR], 1.54; 95%CI, 0.42 to 4.18). There was
no signiﬁcant difference in mortality (OR, 0.79; 95%CI, 0.02 to 3.53) or reinfarction
(OR, 1.05; 95%CI, 0.001 to 4.42) during 1 month to 3.4 years among patients treated
with IPC compared to RIPC.
Conclusions: In STEMI patients undergoing pPCI, available evidence from this
network meta-analysis suggests the non-superiority of IPC vs RIPC on infarct size,
cSTR and incidence of mortality or reinfarction. Further head-to-head in-
vestigations are necessary to evaluate the effect of two adjunctive therapies during
pPCI.GW25-e3237
Usefulness of the index of microcirculatory resistance for assessing clinical
outcome in short term after percutaneous coronary intervention for
sub-acute myocardial infarction
Zhu Qingyi, Zhou Shenghua, Hu Xinqun
The Second Xiangya Hospital of Central South University
Objectives: The objective of this study is to evaluate the clinical value of the index of
microcirculatory resistance (IMR) for assessing short period prognosis of patients with
sub-acute myocardial infarction undergoing elective percutaneous coronary inter-
vention (PCI).
Methods: In 54 stable patients with ST-segment elevation myocardial infarction after
11.13.3days from symptom onset, IMR was measured after successful PCI. 28
(52%) patients had normal IMR value (IMR <32U, 19.87.3U) and 26 (48%) pa-
tients with IMR>32U (60.721.9U). Transthoracic echocardiography, 6 minutes
walking test and major adverse cardiac events (MACE) were followed up at
39.37.23 days.
Results: IMR correlated signiﬁcantly with 6 minutes walking distances (r ¼-0.504,
P<0.001), but not signiﬁcantly with left ventricular ejection fraction (LVEF)
(r ¼-0.074, P ¼0.595). There were no people reoccurred myocardial infarction or stent
re-implantation. The re-admission rate of patients with normal and abnormal IMR was
2 (7%) and 6 (23%), respectively (P¼0.135). Patients with normal IMR had less
recurrence of angina pectoris compared with patients with higher IMR (4[14%] vs. 12
[46%], P¼0.016), and IMR demonstrated signiﬁcant correlation with recurrence of
angina (r ¼0.352, P ¼0.009).
Conclusions: IMR can be regarded as a predictor of the quality of life of patients
with sub-acute myocardial infarction undergoing elective PCI in short term. But it is
not reliable in assessing the left ventricular function recovery and MACE in
short term.GW25-e4113
A randomized clinical study comparing using a single MAC guiding catheter
with conventional approach via radial artery for coronary angiography and
intervention in patients with ST elevation myocardial infarction
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Jianchun Wang, Jincheng Guo
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Objectives: Coronary intervention using transradial approach is common worldwide.
It is normally necessary to use one diagnostic catheter and guiding catheter in primary
percutaneous coronary intervention (PCI) for ST elevation myocardial infarction
(STEMI). It is unknown whether using a single guiding catheter for both nonculpritardiovascular Disease Clinical Research C139
and culprit vessel angiography and intervention during transradial primary PCI is
feasible. The aim of this study is to investigate the feasibility of using a single guiding
catheter (MAC 3.5) for left and right coronary angiography and intervention in pa-
tients with STEMI.
Methods: This was a single-center, prospective, randomized study conducted
from August 2011 to April 2012, 150 patients with STEMI indicated for
transradial primary PCI performed by two experienced transradial operators were
randomized into two groups : MAC group (75 cases) consisted of patients who
underwent coronary angiography and primary PCI by using a single guiding
catheter (MAC3.5). Control group (75 cases) included patients who ﬁrst under-
went coronary angiography with Tiger diagnostic catheter followed by guiding
catheter selection at the operator’s discretion for intervention. The primary out-
comes were cathlab door to balloon time (C2B) and ﬂuoroscopy time. The
secondary outcomes were composite of all-cause death, myocardial infarction or
non-coronary artery bypass graft (non-CABG) -related major bleeding at 30 days
and 2 year.
Results: Baseline patient characteristics were similar between the MAC group and
control group. the sheath placement time (1.84 1.41 min vs 1.620.88 min), the PCI
procedural success rate (88.9% vs 85.9%) and contrast consumption (12629 ml vs
12833 ml) in the two groups were not statistically signiﬁcant (P>0.05). Compare
with the Control group ,C2B time, total procedure time and the overall ﬂuoroscopy
time were signiﬁcantly lower in MAC Group (16.104.49 min vs 18.64 4.20 min ,
P ¼0.001; 29.818.06 min vs 35.7712.01 min, P ¼0.001; 8.40 2.71min vs 10.05
4.90 min, P<0.05, respectively). The secondary endpoints at 30 days was 5 (6.6%)
of 75 patients in the MAC group compared with 4 (5.3%) of 75 in the Control group
(HR 0$98, 95% CI 0.25-3.94; P¼0$98). There is no difference of two-year event-free
survival in the two group (86.7% vs 88%, hazard ratio 0.654, 95% CI 0.28-1.53
P¼0.327), respectively.
Conclusions: A single transradial MAC3.5 guiding catheter for coronary angiography
and intervention seems to be a better option for patients with STEMI for whom pri-
mary PCI is planned. It can shorten C2B time, procedure time and ﬂuoroscopy time.
Further study is required to determine whether this strategy can favorably affect
clinical outcomes.GW25-e4500
Tailored anti-platelet treatment guided by the platelet function assays reduces
the major cardiac events in patients undergoing percutaneous coronary
intervention: a meta- analysis of randomized controlled trials
Xu Lei, Chunjian Li
First Afﬁliated Hospital of Nanjing Medical University
Objectives: To investigate whether the tailored anti-platelet treatments (TAT) guided
by the platelet function assays improve clinical outcome in patients undergoing
percutaneous coronary intervention (PCI).
Methods: We searched the bibliographic databases and the references of relevant
articles, and recruited all randomized controlled trials (RCTs) investigating the efﬁ-
cacy of TAT vs conventional anti-platelet treatment (CAT) in PCI patients with
HOPR. Recruited trials were assessed for risk of bias. Clinical events including car-
diovascular death (CV death), non-fatal myocardial infarction (non-fatal MI), stent
thrombosis (ST) and bleeding were analyzed. Trial sequential analysis was performed
to estimate the strength of evidence.
Results: Eleven RCTs involving 4787 patients with HOPR were recruited, where
2529 patients were randomized into TAT arm, and the other 2258 patients were
randomized into CAT arm. During a follow-up period of 1 to 12 months, the
incidence of CV death, non-fatal MI, and ST were all signiﬁcantly lower in the
TAT arm compared with that in the CAT arm ( (0.7% vs. 1.7%, risk ratio [RR]:
0.37; 95% conﬁdence interval [CI]: 0.19 to 0.72, P¼0.004) ; (1.5% vs. 3.1%,
RR:0.57; 95% CI: 0.39 to 0.83, P¼0.004) ; and (1.2% vs. 2.7%, RR:0.44; 95% CI:
0.27 to 0.73, P¼0.001), respectively). The combined incidence of CV death, non-
fatal MI, and ST were much lower in TAT arm compared to CAT arm (2.9% vs.
7.9%, RR: 0.49; 95% CI: 0.37 to 0.65, P<0.00001). While the incidence of
bleeding was similar between the two arms (5.3% vs. 4.3%, RR: 1.05; 95% CI:
0.86 to 1.27, P¼0.65). Trial sequential analyses demonstrated signiﬁcant evidence
supporting that TAT reduced the risk of combined incidence of CV death, non-fatal
MI and ST.
Conclusions: TAT guided by the platelet function assays reduces the risk of CV
death, non-fatal MI and ST, without additional risk of bleeding.GW25-e4606
Efﬁcacy and safety of cilostazol based triple antiplatelet treatment versus dual
antiplatelet treatment in patients undergoing coronary stent implantation: an
updated meta-analysis of the randomized controlled trials
Jun Chen, Chunjian Li
First Afﬁliated Hospital of Nanjing Medical University, Nanjing, China
Objectives: The aim of this study was to obtain best estimates of the efﬁcacy and
safety of cilostazol-based triple antiplatelet therapy (TAPT: aspirin, clopidogrel and
cilostazol) compared with dual antiplatelet therapy (DAPT: aspirin and clopidogrel) in
patients undergoing coronary stent implantation.C140 JACC Vol 64/16/Suppl C j October 16–1Methods: We searched the literature to identify all randomized clinical trials
examining efﬁcacy and safety of TAPT versus DAPT in patients undergoing
coronary stent implantation. Major efﬁcacy outcomes were death, non-fatal
myocardial infarction (MI), ischemic stroke and stent thrombosis (ST) and the
safety outcome was bleeding. Data were analyzed using the Review Manager 5.0.0
software.
Results: A total of 19 trials involving 7464 patients were included. TAPT and DAPT
were associated with similar rates of death, non-fatal MI, ischemic stroke and ST,
but compared with DAPT, TAPT had lower rates of target lesion revascularization
(TLR) (RR 0.67, 95% CI [0.56, 0.82], P<0.0001) and target vessel revascularization
(TVR) (RR 0.65, 95% CI [0.55, 0.77], P<0.00001), as well as less late loss of
minimal lumen diameter (Mean difference -0.14, 95% CI [-0.17, -0.11],
P<0.00001), and less binary angiographic restenosis (RR 0.54, 95% CI [0.45, 0.65],
P<0.00001). TAPT and DAPT had similar rates of bleeding, but TAPT had
signiﬁcantly higher rates of headache, palpitation, rash and gastrointestinal side-
effects.
Conclusions: Cilostazol-based TAPT compared with DAPT is associated with
improved angiographic outcomes and decreased risk of TLR and TVR but does not
reduce major cardiovascular events and is associated with an increase in minor adverse
events.GW25-e5176
Use of Novel Protective Ballooning Technique with Provisional Stenting for
Treatment of Non-Left Main Coronary Bifurcation Lesions: A Feasibility
Pilot Study
Liu Haibo, Runlin Gao
Department of Cardiology, Cardiovascular Institute and Fu Wai Hospital, Chinese
Academy of Medical Sciences and Peking Union Medical College, Beijing
Objectives: Percutaneous coronary intervention (PCI) of bifurcation lesions is asso-
ciated with a higher risk of adverse events. Recent studies support the use of provi-
sional side branch (SB) stenting, but the risk of SB closure after main vessel (MV)
stenting remains an important concern. We sought to establish and demonstrate the
feasibility and preliminary efﬁcacy of a novel protective ballooning technique (PBT)
for SB protection and treatment during MV stenting.
Methods: The rationale of PBT for SB protection is to preposition a small balloon
(2.0/20mm) in the SB before MV stenting while the proximal makers of the
balloon and the MV stent are being aligned. During deployment of the MV stent
(14-16 atm), the uninﬂated jailed balloon under the stent struts serves to reduce
both carina and plaque shifts due to its spatial occupation in the SB ostium.
Thereafter the jailed balloon is inﬂated at 8-14 atm to dilate the ostium. After
removing the jailed balloon MV stent’s balloon is inﬂated again at 14-16 atm to
correct stent deformation or malapposition. If SB ﬂow is preserved after MV
stenting, the jailed wire will be removed from SB; otherwise it could be used as a
marker to facilitate rewiring SB, and further kissing balloon inﬂation or provi-
sional SB stenting will be performed to restore SB ﬂow. Final intravascular ul-
trasound (IVUS) examinations were selectively performed in some patients to
check the MV stent. Procedural and immediate clinical outcomes were recorded
and reviewed.
Results: This novel technique was successfully adopted in 92 patients with
99 bifurcation lesions. The majority of patients had Medina class 1, 1, 1 bifur-
cation lesions (81%). Final TIMI 3 ﬂow was achieved in 100% of MV and
98% of SB. IVUS revealed optimal deployment of MV stent after ﬁnal inﬂation
in all checked cases (n¼13). Only one patient (1%) had lesions that required
rewiring and provisional stenting of the SB. TIMI 2 ﬂow occurred in one patient
(1%). SB loss occurred in one patient (1%), who suffered a periprocedural
myocardial infarction (MI). No jailed balloon or wire was entrapped during
any PCI.
Conclusions: Provisional stenting of complex coronary bifurcation lesions using a
PBT is associated with a high procedural success rate, improved SB patency, and a
low rate of immediate cardiac events in this feasibility study; however, randomized
trial is needed to further conﬁrm its clinical beneﬁts.GW25-e5296
Safety and efﬁcacy of a new type of Ni-Ti sirolimus-eluting stent with
bioabsorbable polymer in neointimal hyperplasia inhibition
Xiao Yanlong, Liu Bin
the second Hospital of Jilin University
Objectives: The ﬁrst generation drug-eluting stent (DES) was based on 316L stainless
steel and coated with a permanent polymer which will induce chronic inﬂammation
and late in-stent thrombosis. New type of Ni-Ti sirolimus-eluting stent with bio-
absorbable polymer will be the answer to these questions.
Methods: Ni-Ti sirolimus-eluting stents with bioabsorbable polymer (n ¼ 24) and
EXCELTM stents (n ¼ 24) were randomized and implanted in left anterior descending
artery (n ¼ 24) and right coronary (n ¼ 24) of 24 pigs. Coronary angiography,IVUS
and histomorphologic analysis (neointimalarea and lumen area stenosis measurement
after hematoxylin-eosin staining; electron-microscopy scan after ﬁxing with 1%
glutaraldehyde) were performed 90 days after the stents implantation.9, 2014 j GW-ICC Abstracts/Cardiovascular Disease Clinical Research
